$11.70
Today
as of Jul 22, 16:50 ET
Last 30 days
Recent Press Releases & News
Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Korro Bio, Inc. (KRRO) Upgraded to Buy: What Does It Mean for the Stock?
Korro Bio Insider Sold Shares Worth $1,542,970, According to a Recent SEC Filing
Overview
52-week range
$5.20
$56
13% of range
Avg surprise (last 3)
-3.1%
Avg reaction (last 2)
-4.6%
0% positive
Latest IV / EM
73%
EM ±16.7% · $13 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $-1.69 | $-1.60 | -5.6% | +32.1% | -3.4% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-1.92 | — | — | — | — | financials |
| Tue Aug 12, 2025 | Jun/2025 | $-2.74 | $-2.54 | -7.9% | — | — | earnings |
| Wed May 7, 2025 | Mar/2025 | $-2.49 | $-2.60 | +4.2% | — | -5.8% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-2.26 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-2.43 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-2.44 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-65.08 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-63.83 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 11, 2026 | Jun/2026 | OTHER | -$1.54 | -$2.74 | +43.8% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | — | $1M | $1M | $3M | — | $0 | $0 |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-20M | — | $-19M | $-27M | $-25M | — | $-23M | $-24M |
| Net income | $-20M | — | $-18M | $-26M | $-23M | — | $-21M | $-22M |
| EPS (diluted) | $-1.69 | — | $-1.92 | $-2.74 | $-2.49 | — | $-2.26 | $-2.43 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $62M | $22M | $24M | $34M | $64M | $56M | $63M | $91M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $120M | $82M | $98M | $103M | $121M | $132M | $153M | $164M |
| Total assets | $184M | $114M | $162M | $180M | $202M | $226M | $244M | $250M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $64M | $62M | $63M | $65M | $63M | $66M | $64M | $52M |
| Total equity | $120M | $51M | $99M | $115M | $139M | $160M | $180M | $198M |